Neurology

Findings from the phase 2 FIGHT DMD trial suggest an investigational oral thromboxane prostanoid receptor…

Panelist discusses how a neurologist typically manages neurogenic bladder when it stems directly from neurological…

The MyacarinG study post-hoc analysis demonstrated rozanolixizumab's potential to significantly reduce ocular symptoms in gMG,…

Three patients treated with DT-DEC01 showed improvements in various functional tests, including echocardiography, arm movements,…

In the study, most participants are aged 18-60, with 53% female and 73.1% carrying the…

A recent study shows that eteplirsen, a drug promoting dystrophin production, significantly slowed the decline…

Spanning 14 weeks, the study evaluates age-appropriate dosing, safety, pharmacokinetics, and clinical effects through once-weekly…

An expert discusses how Friedreich ataxia significantly impacts quality of life through progressive neurological deterioration…

An expert discusses how Friedreich ataxia is an autosomal recessive neurodegenerative disorder caused by trinucleotide…

Here's some of what is coming soon to NeurologyLive® this week.: Source: Neurology Read More